Research graph
References from The role of super-enhancer-driven lncRNAs in cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1186/s13046-023-02763-5
10.1186/s13046-023-02763-5 · External reference
10.1016/j.cell.2013.03.035
10.1016/j.cell.2013.03.035 · External reference
10.1016/j.pharmthera.2019.02.014
10.1016/j.pharmthera.2019.02.014 · External reference
10.1038/s41467-018-03279-9
10.1038/s41467-018-03279-9 · External reference
10.1038/nature25461
10.1038/nature25461 · External reference
10.1016/j.cell.2023.12.005
10.1016/j.cell.2023.12.005 · External reference
10.1016/j.cell.2023.11.030
10.1016/j.cell.2023.11.030 · External reference
10.1038/35057062
10.1038/35057062 · External reference
Upregulation of superenhancer-driven LncRNA FASRL by USF1 promotes de novo fatty acid biosynthesis to exacerbate hepatocellular carcinoma
10.1002/advs.202204711 · 2022 · External reference
Super-enhancer-associated long noncoding RNA RP11-569A11.1 inhibited cell progression and metastasis by regulating IFIT2 in colorectal cancer
10.1002/jcla.23780 · 2021 · External reference
Histone H3K4me1 strongly activates the DNase I hypersensitive sites in super-enhancers than those in typical enhancers
10.1042/bsr20210691 · 2021 · External reference
10.3390/cancers14122866
10.3390/cancers14122866 · External reference
Non-coding RNA in cancer
10.1042/ebc20200032 · 2021 · External reference
10.1016/j.molcel.2013.01.038
10.1016/j.molcel.2013.01.038 · External reference
10.1146/annurev-genom-122220-093818
10.1146/annurev-genom-122220-093818 · External reference
10.1126/science.1172046
10.1126/science.1172046 · External reference
10.1126/science.aar3958
10.1126/science.aar3958 · External reference
10.1158/0008-5472.can-22-2433
10.1158/0008-5472.can-22-2433 · External reference
Twist1-YY1-p300 complex promotes the malignant progression of HCC thro ugh activation of miR-9 by forming phase-separated condensates at supe r-enhancers and relieved by metformin
10.1016/j.phrs.2023.106661 · 2023 · External reference
CYTOR facilitates formation of FOSL1 phase separation and super enhanc ers to drive metastasis of tumor budding cells in head and neck squamo us cell carcinoma
10.1002/advs.202305002 · 2023 · External reference
10.1016/j.omtn.2023.03.014
10.1016/j.omtn.2023.03.014 · External reference
10.1016/j.csbj.2021.05.006 · Admitted local publication
10.1101/gr.197590.115
10.1101/gr.197590.115 · External reference
10.1038/nature16546
10.1038/nature16546 · External reference
10.1038/s41388-020-01459-w
10.1038/s41388-020-01459-w · External reference
10.1016/j.ccell.2018.11.001
10.1016/j.ccell.2018.11.001 · External reference
10.1053/j.gastro.2020.06.050
10.1053/j.gastro.2020.06.050 · External reference
Super-enhancer associated core regulatory circuits mediate susceptibil ity to retinoic acid in neuroblastoma cells
10.3389/fcell.2022.943924 · 2022 · External reference
Parental imprinting of the mouse H19 gene
10.1038/351153a0 · 1991 · External reference
10.1016/0092-8674(92)90520-m
10.1016/0092-8674(92)90520-m · External reference
10.1186/1476-4598-10-38
10.1186/1476-4598-10-38 · External reference
10.1016/j.cell.2024.10.024
10.1016/j.cell.2024.10.024 · External reference
10.1093/nar/gkaa1046
10.1093/nar/gkaa1046 · External reference
LNCipedia 5: towards a reference set of human long non-coding RNAs
10.1093/nar/gky1031 · 2019 · External reference
10.1038/onc.2017.184
10.1038/onc.2017.184 · External reference
10.1242/jcs.009357
10.1242/jcs.009357 · External reference
10.7554/elife.29224
10.7554/elife.29224 · External reference
Gene regulation by long non-coding RNAs and its biological functions
10.1038/s41580-020-00315-9 · 2020 · External reference
10.1101/gr.132159.111
10.1101/gr.132159.111 · External reference
10.1371/journal.pgen.1003078
10.1371/journal.pgen.1003078 · External reference
10.1038/nrg2521
10.1038/nrg2521 · External reference
10.1016/j.cell.2007.05.022
10.1016/j.cell.2007.05.022 · External reference
10.1016/j.molcel.2008.08.022
10.1016/j.molcel.2008.08.022 · External reference
Biological function of long Non-coding RNA (LncRNA) xist
10.3389/fcell.2021.645647 · 2021 · External reference
10.1038/nature08975
10.1038/nature08975 · External reference
10.1038/nature05519
10.1038/nature05519 · External reference
10.1038/nrneurol.2016.133
10.1038/nrneurol.2016.133 · External reference
10.1038/nature09701
10.1038/nature09701 · External reference
Super enhancer lncRNAs: a novel hallmark in cancer
10.1186/s12964-024-01599-6 · 2024 · External reference
10.1038/s12276-020-0428-7
10.1038/s12276-020-0428-7 · External reference
10.1093/bib/bbaa011
10.1093/bib/bbaa011 · External reference
SELER: a database of super-enhancer-associated lncRNA-directed transcriptional regulation in human cancers
2019 · External reference
The emerging role of super enhancer-derived noncoding RNAs in human cancer
10.7150/thno.49168 · 2020 · External reference
10.1038/nmeth.3317
10.1038/nmeth.3317 · External reference
10.1093/bioinformatics/bts635
10.1093/bioinformatics/bts635 · External reference
10.1093/nar/gku1010
10.1093/nar/gku1010 · External reference
10.1126/science.abj6987
10.1126/science.abj6987 · External reference
10.1038/nprot.2016.095
10.1038/nprot.2016.095 · External reference
10.1038/nbt.1883
10.1038/nbt.1883 · External reference
10.1093/nar/gkaa1087
10.1093/nar/gkaa1087 · External reference
10.1093/nar/gkv1189
10.1093/nar/gkv1189 · External reference
10.1038/nmeth.4197
10.1038/nmeth.4197 · External reference
10.1038/nbt.2862
10.1038/nbt.2862 · External reference
10.1038/nbt.3519
10.1038/nbt.3519 · External reference
10.1186/s13059-014-0550-8
10.1186/s13059-014-0550-8 · External reference
10.1093/bioinformatics/btp616
10.1093/bioinformatics/btp616 · External reference
10.1093/nar/gkv007
10.1093/nar/gkv007 · External reference
A guide to naming human non-coding RNA genes
10.15252/embj.2019103777 · 2020 · External reference
10.1016/j.cell.2013.09.053
10.1016/j.cell.2013.09.053 · External reference
10.1016/j.ymeth.2020.03.005
10.1016/j.ymeth.2020.03.005 · External reference
10.1038/nprot.2018.015
10.1038/nprot.2018.015 · External reference
10.1038/s41587-021-00869-9
10.1038/s41587-021-00869-9 · External reference
Integrative modeling reveals key chromatin and sequence signatures predicting super-enhancers
10.1038/s41598-019-38979-9 · 2019 · External reference
DEEPSEN: a convolutional neural network based method for super-enhancer prediction
10.1186/s12859-019-3180-z · 2019 · External reference
DeepSE: detecting super-enhancers among typical enhancers using only sequence feature embeddings
10.1016/j.ygeno.2021.10.007 · 2021 · External reference
What are super-enhancers?
10.1038/ng.3167 · 2014 · External reference
Super-enhancer-associated TMEM44-AS1 aggravated glioma progression by forming a positive feedback loop with myc
10.1186/s13046-021-02129-9 · 2021 · External reference
The super-enhancer-driven lncRNA LINC00880 acts as a scaffold between CDK1 and PRDX1 to sustain the malignance of lung adenocarcinoma
10.1038/s41419-023-06047-w · 2023 · External reference
Novel insights into chromosomal conformations in cancer
10.1186/s12943-017-0741-5 · 2017 · External reference
10.1186/s12943-022-01518-8
10.1186/s12943-022-01518-8 · External reference
10.1128/mmbr.67.4.657-685.2003
10.1128/mmbr.67.4.657-685.2003 · External reference
LncRNA-based classification of triple negative breast cancer revealed inherent tumor heterogeneity and vulnerabilities
2022 · External reference
10.4161/rna.29624
10.4161/rna.29624 · External reference
10.1038/s41588-023-01620-7
10.1038/s41588-023-01620-7 · External reference
10.1016/j.cell.2011.02.013
10.1016/j.cell.2011.02.013 · External reference
Super-enhancer-associated long noncoding RNA HCCL5 is activated by ZEB1 and promotes the malignancy of hepatocellular carcinoma
10.1158/0008-5472.can-18-0367 · 2019 · External reference
10.1016/j.omtn.2021.10.028
10.1016/j.omtn.2021.10.028 · External reference
E2F1 combined with LINC01004 super-enhancer to promote hepatocellular carcinoma cell proliferation and metastasis
10.1186/s13148-023-01428-6 · 2023 · External reference
Super-enhancer hijacking LINC01977 promotes malignancy of early-stage lung adenocarcinoma addicted to the canonical TGF-β/SMAD3 pathway
10.1186/s13045-022-01331-2 · 2022 · External reference
LINC01503/miR-342-3p facilitates malignancy in non-small-cell lung cancer cells via regulating LASP1
10.1186/s12931-020-01464-3 · 2020 · External reference
Integrative analysis of a novel super-enhancer-associated lncRNA prognostic signature and identifying LINC00945 in aggravating glioma progression
10.1186/s40246-023-00480-w · 2023 · External reference
Super-enhancer-driven lncRNA LIMD1-AS1 activated by CDK7 promotes glioma progression
10.1038/s41419-023-05892-z · 2023 · External reference
10.1053/j.gastro.2018.02.018
10.1053/j.gastro.2018.02.018 · External reference
Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression
10.1038/s41467-018-06081-9 · 2018 · External reference
HSF1 stimulates glutamine transport by super-enhancer-driven lncRNA LINC00857 in colorectal cancer
10.3390/cancers14163855 · 2022 · External reference
A novel oncogenic seRNA promotes nasopharyngeal carcinoma metastasis
10.1038/s41419-022-04846-1 · 2022 · External reference
Bromodomain proteins epigenetically regulate the mitotically associate d lncRNA MANCR in triple negative breast cancer cells
10.1615/critreveukaryotgeneexpr.2023050109 · 2024 · External reference
10.1016/j.bbrc.2020.03.043
10.1016/j.bbrc.2020.03.043 · External reference
10.3390/cancers14163980
10.3390/cancers14163980 · External reference
Immune infiltration and clinical outcome of super-enhancer-associated lncRNAs in stomach adenocarcinoma
10.3389/fonc.2022.780493 · 2022 · External reference
10.1038/cr.2014.35
10.1038/cr.2014.35 · External reference
Genome-wide analysis of the FOXA1 transcriptional regulatory network identifies super enhancer associated LncRNAs in tamoxifen resistance
10.3389/fgene.2022.992444 · 2022 · External reference
METTL3-modified lncRNA DSCAM-AS1 promotes breast cancer progression through inhibiting ferroptosis
10.1007/s10863-024-10024-z · 2024 · External reference
10.1016/j.bbcan.2021.188668
10.1016/j.bbcan.2021.188668 · External reference
Tamoxifen: toxicities and drug resistance during the treatment and prevention of breast cancer
10.1146/annurev.pa.35.040195.001211 · 1995 · External reference
10.1016/j.molcel.2024.09.018
10.1016/j.molcel.2024.09.018 · External reference
LncRNA DSCAM-AS1 acts as a sponge of miR-137 to enhance tamoxifen resistance in breast cancer
10.1002/jcp.27105 · 2018 · External reference
10.1016/j.isci.2019.06.025
10.1016/j.isci.2019.06.025 · External reference
Anchoring super-enhancer-driven oncogenic lncRNAs for anti-tumor therapy in hepatocellular carcinoma
10.1016/j.ymthe.2022.11.013 · 2023 · External reference
Super enhancer-regulated LncRNA LINC01089 induces alternative splicing of DIAPH3 to drive hepatocellular carcinoma metastasis
10.1158/0008-5472.can-23-0544 · 2023 · External reference
10.1016/j.cell.2013.03.036
10.1016/j.cell.2013.03.036 · External reference
10.1016/j.ccr.2013.11.003
10.1016/j.ccr.2013.11.003 · External reference
3rd. bromodomains: a new target class for drug development
10.1038/s41573-019-0030-7 · 2019 · External reference
Bromodomain inhibitor OTX015 in patients with lymphoma or multiple mye loma: a dose-escalation, open-label, pharmacokinetic, phase 1 study
10.1016/s2352-3026(16)00021-1 · 2016 · External reference
10.1038/nature10334
10.1038/nature10334 · External reference
10.1038/cr.2014.71
10.1038/cr.2014.71 · External reference
10.1038/leu.2013.338
10.1038/leu.2013.338 · External reference
10.1158/2767-9764.crc-23-0639
10.1158/2767-9764.crc-23-0639 · External reference
10.1016/j.ejmech.2023.116052
10.1016/j.ejmech.2023.116052 · External reference
10.1016/j.molcel.2015.06.032
10.1016/j.molcel.2015.06.032 · External reference
10.1016/j.cell.2014.10.024
10.1016/j.cell.2014.10.024 · External reference
10.1016/j.cell.2015.08.063
10.1016/j.cell.2015.08.063 · External reference
10.1158/0008-5472.can-19-0119
10.1158/0008-5472.can-19-0119 · External reference
Correction: the CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer
10.1038/s41416-024-02606-w · 2024 · External reference
10.3390/ijms21186479
10.3390/ijms21186479 · External reference
10.1038/nrclinonc.2016.26
10.1038/nrclinonc.2016.26 · External reference
10.1136/gutjnl-2016-311818
10.1136/gutjnl-2016-311818 · External reference
Disruption of super-enhancer-driven tumor suppressor gene RCAN1.4 expression promotes the malignancy of breast carcinoma
10.1186/s12943-020-01236-z · 2020 · External reference
Risdiplam: first approval
10.1007/s40265-020-01410-z · 2020 · External reference
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits sele ctive activity in high-risk neuroblastoma
10.1038/s41467-021-26640-x · 2021 · External reference
10.1056/nejmoa2210027
10.1056/nejmoa2210027 · External reference
